Sacituzumab govitecan and other antibody-drug conjugates targeting trophoblast cell-surface antigen 2 (Trop-2) in breast cancer.

ABSTRACT:

SUBMITTER: Matusz-Fisher A 

PROVIDER: S-EPMC9577799 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature